Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-20T05:27:09.917Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug Combinations for Chronic Depression

Published online by Cambridge University Press:  29 January 2018

Peter M. Graham
Peter M. Graham*
Affiliation:
Mental Health Services, Bentley Clinic, 35 Mills Street, Cannington 6107, Western Australia
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 145 , Issue 2 , August 1984 , pp. 214
Copyright
Copyright © Royal College of Psychiatrists, 1984 

References

Baloh, R. W. & Spooner, J. W. (1982) Myoclonus and Ocular Oscillations induced by L-Tryptophan. Annals of Neurology, 11, 95–7.CrossRefGoogle ScholarPubMed
Grahame-Smith, D. G. (1971) Studies of vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with monoamine oxidase inhibitors and L-tryptophan. Journal of Neurochemistry, 13, 1053–66.Google Scholar
Grahame-Smith, D. G., Green, A. R. (1974) The role of brain 5-Hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition. British Journal of Pharmacology, 52, 19–26.Google Scholar
Pare, C. M. B. (1963) Potentiation of monoamine-oxidase inhibitors by tryptophan. Lancet, ii, 527–8.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.